In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2747-2748

  Gikas, Achilleas ^a   Spyridaki, Ioanna ^a   Psaroulaki, Anna ^a   Kofterithis, Diamantis ^a   Tselentis, Yannis ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; OFLOXACIN; PEFLOXACIN; RIFAMPICIN; TETRACYCLINE; TROVAFLOXACIN;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; COXIELLA BURNETII; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; Q FEVER;

EID: 0031716375     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2747     Document Type: Article

References (13)

1. Jabarit-Aldighieri, N., H. Torres, and D. Raoult. 1992. Susceptibility of Rickettsia conori, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:2529-2532.
2. Keren, G., A. Keysary, R. Goldwasser, and E. Rubinstein. 1994. The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in in-vitro systems. J. Antimicrob. Chemother. 33:1253-1255.
3. Levy, P. Y., M. Drancourt, J. Etienne, J. C. Auvergnat, J. Beytout, J. M. Sainty, F. Goldstein, and D. Raoult. 1991. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob. Agents Chemother 35:533-537.
4. Maurin, M., and D. Raoult. 1996. Optimum treatment of intracellular infection. Drugs 52:45-49.
5. Maurin, M., A. M. Benoliel, P. Bongrand, and D. Raoult. 1992. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect. Dis. 166:1097-1102.
6. Maurin, M., and D. Raoult. 1993. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents Chemother. 37:2633-2637.
7. Raoult, D. 1991. Antibiotic treatment of rickettsiosis, recent advances and current concepts. Eur. J. Epidemiol. 7:276-281.
8. Raoult, D. 1993. Treatment of Q fever. Antimicrob. Agents Chemother. 37:1733-1736.
9. Raoult, D., and T. Marrie. 1995. Q fever. Clin. Infect. Dis. 20:489-496.
10. Raoult, D., H. Torres, and M. Drancourt. 1991. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 35:2070-2077.
11. Torres, H., and D. Raoult. 1993. In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay. Antimicrob. Agents Chemother. 37:491-494.
12. Tselentis, Y., A. Gikas, D. Kodteridis, E. Kyriakakis, N. Lydataki, D. Bouros, and N. Tsaparas. 1995. Q fever in the Greek island of Crete: epidemiological, clinical, and therapeutic data from 98 cases. Clin. Intect. Dis. 20:1311-1316.
13. Yeaman, M. R., L. A. Mitscher, and O. G. Baca. 1987. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 31:1079-1084.